Your browser doesn't support javascript.
loading
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021.
Ascierto, Paolo A; Avallone, Antonio; Bhardwaj, Nina; Bifulco, Carlo; Bracarda, Sergio; Brody, Joshua D; Buonaguro, Luigi; Demaria, Sandra; Emens, Leisha A; Ferris, Robert L; Galon, Jérôme; Khleif, Samir N; Klebanoff, Christopher A; Laskowski, Tamara; Melero, Ignacio; Paulos, Chrystal M; Pignata, Sandro; Ruella, Marco; Svane, Inge Marie; Taube, Janis M; Fox, Bernard A; Hwu, Patrick; Puzanov, Igor.
Afiliação
  • Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy. paolo.ascierto@gmail.com.
  • Avallone A; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.
  • Bhardwaj N; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bifulco C; Providence Genomics and Earle A. Chiles Research Institute, Portland, OR, USA.
  • Bracarda S; Medical and Translational Oncology Unit, Department of Oncology, Azienda Ospedaliera Santa Maria, Terni, Italy.
  • Brody JD; Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Buonaguro L; Department of Experimental Oncology, Innovative Immunological Models Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.
  • Demaria S; Department of Radiation Oncology, Weill Cornell Medical College; Sandra and Edward Meyer Cancer Center; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Emens LA; Magee Women's Hospital/UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Ferris RL; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Galon J; INSERM, Laboratory of Integrative Cancer Immunology/Equipe Labellisée Ligue Contre Le Cancer/Centre de Recherche Des Cordeliers, Sorbonne Université, Université Paris Cité, Marseille, France.
  • Khleif SN; The Loop Immuno Oncology Laboratory, Georgetown University Medical School, Washington, DC, USA.
  • Klebanoff CA; Human Oncology and Pathogenesis Program, Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center (MSKCC)/Center for Cell Engineering, MSKCC/Parker Institute for Cancer Immunotherapy/Weill Cornell Medical College, New York, NY, USA.
  • Laskowski T; Head of New Therapeutic Products - Personalized Medicine, Lonza Global, Houston, TX, USA.
  • Melero I; Department of Immunology and Immunotherapy, Clinica Universidad de Navarra and CIBERONC, Pamplona, Spain.
  • Paulos CM; Winship Cancer Institute at Emory University, Atlanta, GA, USA.
  • Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.
  • Ruella M; Center for Cellular Immunotherapies and Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, USA.
  • Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Taube JM; Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA.
  • Fox BA; Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Cancer Institute, Portland, OR, USA.
  • Hwu P; Moffitt Cancer Center, Tampa, FL, USA.
  • Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
J Transl Med ; 20(1): 257, 2022 06 07.
Article em En | MEDLINE | ID: mdl-35672823

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Melanoma Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Melanoma Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article